Italie - italien - AIFA (Agenzia Italiana del Farmaco)

astrazeneca ab - bambuterolo cloridrato - bambuterolo cloridrato

Italie - italien - AIFA (Agenzia Italiana del Farmaco)

astrazeneca ab - altri antisettici e disinfettanti - altri antisettici e disinfettanti

Union européenne - italien - EMA (European Medicines Agency)

astrazeneca ab - durvalumab - carcinoma, polmone non a piccole cellule - agenti antineoplastici - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

Union européenne - italien - EMA (European Medicines Agency)

astrazeneca ab - la metformina cloridrato, saxagliptin, dapagliflozin - diabete mellito, tipo 2 - farmaci usati nel diabete - qtrilmet è indicato negli adulti dai 18 anni di età con diabete mellito di tipo 2:migliorare il controllo glicemico quando metformina con o senza sulfonilurea (su) e saxagliptin o dapagliflozin non forniscono un adeguato controllo glicemico. quando già in trattamento con metformina e saxagliptin e dapagliflozin.

Italie - italien - AIFA (Agenzia Italiana del Farmaco)

astrazeneca s.p.a. - goserelin - goserelin

Italie - italien - AIFA (Agenzia Italiana del Farmaco)

astrazeneca s.p.a. - atenololo e altri antiipertensivi - atenololo e altri antiipertensivi

Italie - italien - AIFA (Agenzia Italiana del Farmaco)

astrazeneca uk limited - proguanil - proguanil

Italie - italien - AIFA (Agenzia Italiana del Farmaco)

astrazeneca s.p.a. - zafirlukast - zafirlukast

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - tamoxifenum - compresse rivestite con film - tamoxifenum 20 mg ut tamoxifeni citras, lactosum monohydricum 234 mg, maydis amylum, gelatina, carmellosum natricum conexum, magnesii stearas, hypromellosum, macrogolum 300, e 171, pro compresso obducto corresp. natrium 0.683 mg. - oncologicum - synthetika

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

astrazeneca ag - terbutalini sulfas - polvere per inalazione - terbutalini sulfamidici, 500 mg pro dosi, lactosum, dosi pro vaso 200. - bronchospasmolytikum - synthetika